For tumor types that express high levels of IL6, such as GBM,80 our in vivo experimental results suggest that tocilizumab may be a potential therapy for glioma patients, at least as an adjuvant therapy combined with current chemotherapy. The gene discussed is IL6; the disease is glioma.